Tecan is one of the first companies to meet the requirements of the European Union’s In Vitro Diagnostic Regulation (IVD-R) 2017/746 (Annex IX, Chapter I and III).
Venomtech is harnessing the power of natural venoms produced by animals to generate compound libraries that are used in drug discovery studies.
Beckman Coulter has launched its DxH 560 AL, a tabletop analyser geared to reduce the time and resource constraints faced by small to mid-sized laboratories.
Tecan has launched the Fluent Mix and Pierce Workstation to provide end-to-end automation for whole blood pipetting in clinical environments.
ViroStat is a primary manufacturer of antibody pairs validated for use in enzyme-linked immunosorbent assay (ELISA) and lateral-flow applications. These OEM pairs are currently used in numerous IVD products for antigen detection.
The Health and Care Professions Council (HCPC) has unveiled its new Corporate Strategy, setting out a bold agenda for the next five years and a clear vision for the future.
A webinar to be held on 21 January (2.00 pm) to include a presentation of Menarini’s different offerings in surgical specimen management as well as a live demonstration of these instruments. Click on this story for the link to register.
Diagnostica Stago has developed an automated test set-up to enable monitoring of the new, highly-active haemophilia drug emicizumab. The new protocol also eliminates any carry-over concerns.
Sysmex’s haematological inflammation parameters support early diagnosis so that targeted treatment can be started, changed or modified. Monitoring patients with inflammatory diseases and the success of their therapy helps to avoid antibiotic overuse.
Roche has announced the CE-IVD launch of its automated digital pathology algorithms uPath HER2 (4B5) image analysis and uPath Dual ISH image analysis for breast cancer to help determine the best treatment strategy for each patient.
Proscia, a provider of digital and computational pathology solutions, has announced that Laboratorium Pathologie Oost-Nederland (LabPON), the first laboratory in the world to 100% digital pathology diagnosis, will deploy its Concentriq platform.
A new textbook entitled ‘Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives’ explains immunotherapies for different types of cancer, helping users carry out research or create alternatives for drug development.
New research on the structure and dynamics of a branched form of DNA called a three-way junction could lead to more effectively targeted treatments for degenerative disorders like Huntington’s disease.
Proteomedix, the Swiss cancer diagnostics company, has announced that the results of PROPOSe, a prospective multicentre study of Proclarix in clinical routine use, have been published in European Urology Oncology.